Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Optimizing An Ex Vivo Organ Perfusion of the Mouse Pancreas to Generate a Type I Diabetes Model

FY 2022-23

Summary
Type 1 diabetes (T1D) is an autoimmune disease that destroys insulin-producing beta cells and has no cure. Disease modelling aids the understanding of the pathophysiology and developing potential therapeutics. Currently, streptozotocin (STZ) is used to generate T1D mice models. However, inducing diabetes in vivo often has adverse effects on the animal's health (ex. fatal hypoglycemia, STZ-induced liver toxicity) and consequently experimental results. A T1D model that fully captures the organ physiology and is easily manipulatable is needed. Ex vivo organ perfusion (EVOP) is the isolation and maintenance of an organ outside the animal. Developing a T1D model through this culture method allows us to study the organ in real time, enabling immediate and accurate data collection and analysis. This isolated tightly controlled system would eliminate complications of mouse models. This project aims to optimize EVOP culture conditions of the mouse pancreas to generate an EVOP model of T1D using STZ. The pancreas will be isolated and cannulated to attach to the bioreactor previously developed by Rogers’ lab. Waymouth media with supplements will be used, and additional supplements will be tested to optimize the EVOP culture conditions to sustain extended growth. STZ will be administered at a single high dose (300mg/kg) for 2 day culture or multiple low doses (40mg/kg) for 5 day culture. Histology staining (H&E, TUNEL) and functional tests (Glucose-stimulated insulin secretion and c-peptide measurement) will be used to evaluable tissue viability. Optimization of the mouse pancreas EVOP culture to generate an ex vivo T1D model provides a platform for understanding the disease, therapeutic development, and paves the way for translatable studies.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486225
Name
Ping Yvonne
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Optimizing An Ex Vivo Organ Perfusion of the Mouse Pancreas to Generate a Type I Diabetes Model
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Beta Cells; Bioreactor; Diabetes; Disease Model; Ex-Vivo Organ Perfusion; Organ Culture; Pancreas; Type 1 Diabetes
Abstract
Type 1 diabetes (T1D) is an autoimmune disease that destroys insulin-producing beta cells and has no cure. Disease modelling aids the understanding of the pathophysiology and developing potential therapeutics. Currently, streptozotocin (STZ) is used to generate T1D mice models. However, inducing diabetes in vivo often has adverse effects on the animal's health (ex. fatal hypoglycemia, STZ-induced liver toxicity) and consequently experimental results. A T1D model that fully captures the organ physiology and is easily manipulatable is needed. Ex vivo organ perfusion (EVOP) is the isolation and maintenance of an organ outside the animal. Developing a T1D model through this culture method allows us to study the organ in real time, enabling immediate and accurate data collection and analysis. This isolated tightly controlled system would eliminate complications of mouse models. This project aims to optimize EVOP culture conditions of the mouse pancreas to generate an EVOP model of T1D using STZ. The pancreas will be isolated and cannulated to attach to the bioreactor previously developed by Rogers’ lab. Waymouth media with supplements will be used, and additional supplements will be tested to optimize the EVOP culture conditions to sustain extended growth. STZ will be administered at a single high dose (300mg/kg) for 2 day culture or multiple low doses (40mg/kg) for 5 day culture. Histology staining (H&E, TUNEL) and functional tests (Glucose-stimulated insulin secretion and c-peptide measurement) will be used to evaluable tissue viability. Optimization of the mouse pancreas EVOP culture to generate an ex vivo T1D model provides a platform for understanding the disease, therapeutic development, and paves the way for translatable studies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ping, Yvonne
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~